Foreign body granulomas after all injectable dermal fillers: Part 1. possible causes

Plastic and Reconstructive Surgery

Volumn 123, Issue 6, 2009, Pages 1842-1863

  Lemperle, Gottfried ^a,b,c   Gauthier Hazan, Nelly ^a,b,c   Wolters, Marianne ^a,b,c   Eisemann Klein, Marita ^a,b,c   Zimmermann, Ute ^a,b,c   Duffy, David M ^a,b,c  

^a University of California ^*

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLAMIDE DERIVATIVE; COLLAGEN; COLLAGEN FIBER; COLLAGEN IMPLANT; CORTICOSTEROID; DEXTRAN; FILLER; HYALURONIC ACID; HYDROXYAPATITE; INJECTABLE DERMAL FILLER; MICROSPHERE; PEGINTERFERON ALPHA2A; POLY(METHYL METHACRYLATE); POLYACRYLAMIDE; POLYLACTIC ACID; POLYMACON; PYRITINOL; RIBOFLAVIN; SILICONE; SILICONE GEL; UNCLASSIFIED DRUG;

CELL INFILTRATION; CLINICAL FEATURE; CYSTIC GRANULOMA; DISEASE CLASSIFICATION; EDEMATOUS GRANULOMA; FACE EDEMA; FIBROBLAST; FOREIGN BODY GRANULOMA; GIANT CELL; HEPATITIS C; HISTOPATHOLOGY; HUMAN; IMPLANTATION; INCIDENCE; INFLAMMATORY CELL; INJECTION; MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCLEROSING GRANULOMA; SKIN REDNESS; SKIN SWELLING; TREATMENT INDICATION; ADULT; ARTICLE; CASE REPORT; DERMIS; FEMALE; MALE; MIDDLE AGED;

ADULT; DERMIS; FEMALE; GRANULOMA, FOREIGN-BODY; HUMANS; INJECTIONS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 67649389683     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e31818236d7     Document Type: Review

References (130)

1. Rohrich RJ, Rios JL, Fagien S. Role of new fillers in facial rejuvenation: A cautious outlook. Plast Reconstr Surg. 2003; 112:1899.
2. Lowe N. New filler agents: What can we learn from Europe? Pract Dermatol. 2004;6:29.
3. André P, Lowe NJ, Clerici TH, Zimmermann U. Adverse reactions to dermal fillers: A review of European experiences. J Cosmet Laser Ther. 2005;7:171.
4. Bigata X, Ribera M, Bielsa I, Ferrándiz C. Adverse granulomatous reaction after cosmetic dermal silicone injection. Dermatol Surg. 2001;27:198.
5. Duffy DM. Tissue injectable liquid silicone: New perspectives. In: Klein AW, ed. Tissue Augmentation in Clinical Practice: Procedures and Techniques. 2nd ed. New York: Taylor & Francis; 2005:159.
6. Moscona RR, Bergman R, Friedman-Birnbaum R. An unusual late reaction to Zyderm I injections: A challenge for treatment. Plast Reconstr Surg. 1993;92:331.
7. Lombardi T, Samson J, Plantier F, et al. Orofacial granuloma after injection of cosmetic fillers: Histopathologic and clinical study of 11 cases. J Oral Pathol Med. 2004;33:115.
8. Lupton JR, Alster TS. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol Surg. 2000;26:135.
9. Shafir R, Amir A, Gur E. Long-term complications of facial injections with Restylane (injectable hyaluronic acid). Plast Reconstr Surg. 2000;106:1215.
10. Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with Artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg. 2003;29:573.
11. Laglenne S. Un nouveau produit de comblement des rides, entirement resorbable. Dermatologie. 2000;54:30.
12. Christensen LH, Breiting VB, Aasted A, Jørgensen A, Kebuladze A. Long-term effects of polyacrylamide hydrogel on human breast tissue. Plast Reconstr Surg. 2003;111:1883.
13. Mazzoleni F, Dominici C, Lotti T, et al. Formacryl: Un nuovo biopolimero al servizio della medicina "piu un endoprotesi che un filler." Dermatologia. 2000;1:13.
14. Bergeret-Galley C, Latouche X, Illouz YG. The value of a new filler material in corrective and cosmetic surgery: DermaLive and DermaDeep. Aesthetic Plast Surg. 2001;25: 249.
15. Cooperman LS, Mackinnon V, Bechler G, Pharriss BB. Injectable collagen: A six-year clinical investigation. Aesthetic Plast Surg. 1985;9:145.
16. Charriere G, Bejot M, Schnitzler L, Ville G, Hartmann DJ. Reactions to a bovine collagen implant: Clinical and immunologic study in 705 patients. J Am Acad Dermatol. 1989; 21:1203.
17. Castrow FF, Krull EA. Injectable collagen implant: Update. J Am Acad Dermatol. 1983;9:889.
18. Hanke CW. Adverse reactions to bovine collagen. In: Klein AW, ed. Tissue Augmentation in Clinical Practice: Procedures and Techniques. New York: Marcel Dekker; 1998:145-154.
19. Lowe NJ, MaxwellA,LoweP,Duick MG, ShahK.Hyaluronic acid skin fillers: Adverse reactions and skin testing. J Am Acad Dermatol. 2001;45:930.
20. André P. Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA, Q-Medical, Sweden) in European countries: A retrospective study from 1997 to 2001. J Eur Acad Dermatol Venereol. 2004;18:422.
21. Friedman PM, Mafong EA, Kauvar NB, Geronemus RG. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg. 2002; 28:491.
22. Maas CS, Gnepp DR, Bumpous J. Expanded polytetrafluoroethylene (Gore-Tex soft tissue patch) in facial augmentation. Arch Otolaryngol Head Neck Surg. 1993;119:1008.
23. Rudolph C, Soyer HP, Schuller-Petrovic S, Kerl H. Foreign body granulomas dueto injectable aesthetic microimplants. Am J Surg Pathol. 1999;23:113.
24. Vleggaar D. Soft-tissue augmentation and the role of poly-L-lactic acid. Plast Reconstr Surg. 2006;118(3 Suppl.):46S.
25. Greenberg JH. Information postal survey of selected physicians indermatology. Presentedatthe American Academy of Dermatology Meeting, Dallas, Texas, December 7-12, 1991.
26. Orentreich DS. Liquid injectable silicone: Techniques for soft tissue augmentation. Clin Plast Surg. 2000;27:595.
27. Fulton JE, Jr, Porumb S, Caruso JC, Shitabata PK. Lip augmentation with liquid silicone. Dermatol Surg. 2005;31:1577.
28. Jones DH, Carruthers A, Orentreich D, et al. Highly purified 1000-cSt silicone oil for treatment of human immunodeficiency virus-associated facial lipoatrophy: An open pilot trial. Dermatol Surg. 2004;30:1279.
29. Shapiro PE. Noninfectious granulomas. In Lever's Histopathology of the Skin. 8th ed. Philadelphia: Raven; 1997:317-340.
30. Lemperle G, Rullan PP, Gauthier-Hazan N. Avoiding and treating dermal filler complications. Plast Reconstr Surg. 2006;118(3 Suppl.):92S.
31. Niechajev A. Lip enhancement: Surgical alternatives and histologic aspects. Plast Reconstr Surg. 2000;105:1173.
32. Naoum C, Dasiou-Plakida D, Pantelidaki K, Dara C, Chrisanthakis D, Perissios A. A histological and immunohistochemical study of medical-grade fluid silicone. Dermatol Surg. 1998; 24:867.
33. Eppley BL, Summerlin D-J, Prevel CD, Sadove AM. Effects of positively charged biomaterial for dermal and subcutaneous augmentation. Aesthetic Plast Surg. 1994;18:413.
34. Hubmer MG, Hoffmann C, Popper H, Scharnagl E. Expanded polytetrafluoroethylene threads for lip augmentation induce foreign body granulomatous reaction. Plast Reconstr Surg. 1999;103:1277.
35. Garcia-Domingo MI, Alijtas-Reig J, Cistero-Bahima A, Tresserra F, Enrique E. Disseminated and recurrent sarcoid-like granulomatous panniculitis due to bovine collagen injection. J Investig Allergol Clin Immunol. 2000;10:107.
36. Lemperle G, Morhenn VB, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg. 2003;27:354.
37. Stegman SJ, Chu S, Armstrong RA. Adverse reactions to bovine collagen implant: Clinical and histologic features. J Dermatol Surg Oncol. 1988;14:39.
38. Morgan AM. Localized reactions to injected therapeutic materials. J Cutan Pathol. 1995;22:289.
39. Hanke CW, Higley HR, Jolivette DM, Swanson NA, Stegman SJ. Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant. J Am Acad Dermatol. 1991;25:319.
40. Barr RJ, King F, McDonald RM, Bartlow GA. Necrobiotic granulomas associated with bovine collagen test site injections. J Am Acad Dermatol. 1982;6:867.
41. Brooks N. A foreign body granuloma produced by an injectable collagen implant at a test site. J Dermatol Surg Oncol. 1982;8:111.
42. Rapaport MJ, Vinnik C, Zarem H. Injectable silicone: Cause of facial nodules, cellulites, ulceration, and migration. Aesthetic Plast Surg. 1996;20:267.
43. Drake LA, Dinehart SM, Farmer ER,etal. Guidelinesofcare for soft tissue augmentation: Collagen implants. J Am Acad Dermatol. 1996;34:698.
44. Baumann LS, Kerdel F. The treatment of bovine collagen allergy with cyclosporin. Dermatol Surg. 1999;25:247.
45. Heise H, Zimmermann R, Heise P. Temporary granulomatous inflammation following collagen implantation. J Craniomaxillofac Surg. 2001;29:238.
46. Williams CT, Williams WJ. Granulomatous inflammation: A review. J Clin Pathol. 1983;36:723.
47. Maly A, Regev E, Maly B. Tissue reaction to liquid silicone simulating low-grade liposarcoma following lip augmentation. J Oral Pathol Med. 2004;33:314.
48. Sidwell RU, McL Johnson N, Francis N, Bunker CB. Cutaneous sarcoidal granulomas developing after Artecoll facial cosmetic filler in a patient with newly diagnosed systemic sarcoidosis. Clin Exp Dermatol. 2006;31:208.
49. Coleman DL, King RN, Andrade JD. The foreign body reaction: A chronic inflammatory response. J Biomed Mater Res. 1974;6:199.
50. Requena C, Izquierdo MJ, Navarro M, et al. Adverse reactions to injectable aesthetic microimplants. Am J Dermatopathol. 2001;23:197.
51. Duffy DM. Liquid silicone for soft tissue augmentation: Histological, clinical, and molecular perspectives. Dermatol Surg. 2007;31:1530.
52. Hexsel DM, Hexsel CL, Iyengar V. Liquid injectable silicone: History, mechanism of action, indications, technique, and complications. Semin Cutan Med Surg. 2003;22:107.
53. Rohrich RJ, Potter JK. Liquid injectable silicone: Is there a role as cosmetic soft-tissue filler? Plast Reconstr Surg. 2004; 113:1239.
54. Mupparapu M, Mozaffari E. Bilateral calcifications secondary to synthetic soft tissue augmentation of the cheeks: Report of a case. Dentomaxillofac Radiol. 2002;31:388.
55. Zimmermann US, Clerici TJ. The histological aspect of fillers complications. Semin Cutan Med Surg. 2004;23:241.
56. Salmi R, Boari B, Manfredini R. Siliconoma: An unusual entity for the internist. Am J Med. 2004;116:67.
57. Achauer BM. A serious complication following medical grade silicone injections of the face. Plast Reconstr Surg. 1983;71:251.
58. Schoeller T, Gschnitzer C, Wechselberger G, et al. Chronisch rezidivierende, local destruierende Silikonome nach Brustaugmentation durch fluessiges Silikonoel. Chirurg. 2000;71:1370.
59. Spira M. Failure to remove soft tissue injected with liquid silicone with the use of suction and honesty in scientific medical reports. Plast Reconstr Surg. 2000;105:1909.
60. Maas CS, Papel ID, Greene D, Stoker DA. Complications of injectable synthetic polymers in facial augmentation. Dermatol Surg. 1997;23:871.
61. Ficarra G, Mosqueda-Taylor A, Carlos R. Silicone granuloma of the facial tissue: A report of seven cases. Oral Surg Oral Med Oral Pathol. 2002;94:65.
62. Alani RM, Busam K. Acupuncture granulomas. J Am Acad Dermatol. 2001;45:225.
63. Senet P, Bachelez H, Ollivaud L, Vignon-Pennamen D, Dubertret L. Minocycline for the treatment of cutaneous silicone granulomas. Br J Dermatol. 1999;140:985.
64. Rapaport MJ. Granuloma annulare caused by injectable collagen. Arch Dermatol. 1984;120:837.
65. Moody BR, Sengelmann RD. Self-limited adverse reaction to human-derived collagen injectable product. Dermatol Surg. 2000;26:936.
66. Bergeret-Galley C. Comparison of resorbable soft tissue fillers. Aesthetic Surg J. 2004;24:33.
67. Raulin C, Greve B, Hartschuh W, Soegding K. Exudative granulomatous reaction to hyaluronic acid (Hylaform). Contact Dermatitis. 2000;43:178.
68. Distante F, Bandiera A, Bellini R, et al. Studio multricentrico italiano sull'efficacia e la tollerabilita dell'acido ialuronico di origine non animale (Restylane) nel trattamento degli inestetismi del volto. Gio Ital Dermatol Venerol. 2001; 136:293.
69. Micheels P. Human anti-hyaluronic acid antibodies: Is it possible? Dermatol Surg. 2001;27:185.
70. Hoenig JF, Brink U, Korabiowska M. Severe granulomatous allergic tissue reaction after hyaluronic acid injection in the treatment of facial lines and its surgical correction. J Craniofac Surg. 2003;14:197.
71. Fernandez-Acenero MJ, Zamora E, Borbujo J. Granulomatous foreign body reaction against hyaluronic acid: Report of a case after lip augmentation. Dermatol Surg. 2003;29: 1225.
72. Saylan Z. Facial fillers and their complications. Aesthetic Surg J. 2003;23:221.
73. Dal SaccoD,CozzaniE,ParodiA,ReboraA.Scar sarcoidosis after hyaluronic acid injection. Int J Dermatol. 2005;44:411.
74. Edwards PC, Fantasia JE, Iovino R. Foreign body reaction to hyaluronic acid (Restylane): An adverse outcome of lip augmentation. J Oral Maxillofac Surg. 2006;64:1296.
75. Ghislanzoni M, Bianchi F, Barbareschi M, Alessi E. Cutaneous granulomatous reactiontoinjectable hyaluronic acid gel. Br J Dermatol. 2006;154:755.
76. Chen AL, Desai P, Adler EM, Di Cesare PE. Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee: A report of six cases. J Bone Joint Surg (Am.) 2002; 84:1142.
77. Mang WL, Sawatzki K. Fremdkoerperreaktion nach Implantation von PMMA (Polymethylmethacrylat) zur Weichteilaugmentation. Z Hautkr. 1998;73:42.
78. HoffmannC,Schuller-PetrovicS,Soyer HP, Kerl H.Adverse reactions after cosmetic lip augmentation with permanent biologically inert implant materials. Am Acad Dermatol. 1999; 40:100.
79. Reisberger E-M, Landthaler M, Wiest L,SchröderJ,Stolz W. Foreign body granulomas caused by polymethylmethacry-late microspheres. Arch Dermatol. 2003;139:17.
80. Alcalay J, Alkalay R, Gat A, Yorav S. Late-onset granulomatous reaction to Artecoll. Dermatol Surg. 2003;29:859.
81. Kim KJ, Lee HW, Lee MW, Choi JH, Moon KC, Koh JK. Artecoll granuloma: A rare adverse reaction induced by microimplant in the treatment of neck wrinkles. Dermatol Surg. 2004;30:545.
82. Carruthers A, Carruthers JD. Polymethylmethacrylate microspheres/ collagenas atissue augmenting agent: Personal experience over 5 years. Dermatol Surg. 2005;31:1561.
83. Conejo-Mir JS, Sanz Guirado SS, Angel Muñoz M. Adverse granulomatous reaction to Artecoll treated by intralesional 5-fluorouracil and triamcinolone injections. Dermatol Surg. 2006;32:1079.
84. Giordano GG, Chevez-Barrios P, Refojo MF, Garcia CA. Biodegradation and tissue reaction to intravitreous biodegradable poly(D,L-lactic-co-glycolic) acid microspheres. Curr Eye Res. 1995;14:761.
85. Valantin M-A, Aubron-Olivier C, Ghosn J, et al. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: Results of the open-label study VEGA. AIDS. 2003;17:2471.
86. Moyle GJ, Lysakova L, Brown S, et al. A randomized openlabel study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med. 2004;5:82.
87. BauerU.Improvementoffacial aestheticsat40months with injectable poly-L- lactic acid (PLLA). Poster presentation at the at the International Society of Aesthetic Plastic Surgery Congress, Houston, Texas, August 28-31, 2004.
88. Beljaards RC, de Roos K-P, Bruins FG. NewFill for skin augmentation: A new filler or failure? Dermatol Surg. 2005; 31:772.
89. van der Lei B, Cromheecke M. Response to "New-fill injections may induce late-onset foreign body granulomatous reaction." Plast Reconstr Surg. 2006;118:265.
90. Oppel T, Schaller M, Flaig M, Korting HC. Fremdkoerpergranulome nach dermaler Injektion eines auf Polymilchsaeure basierenden Implantates zur Behandlung von Falten. J Deutsche Dermatol Ges. 2003;1:220.
91. Pons-Giraud A. Actualisation des effets secondaires des produits de comblemment des rides. Nouv Dermatol. 2003; 22:205.
92. Corbiget-Escalier F, Petrella T, Janin-Magnificat C, et al. Episodes d'angio-oedemesde laface avec nodulesdegranulomes a corps etrangers deux ans apr s des injections d'un produit de comblement des rides: Probable responsibilite du New-Fill. Nouv Dermatol. 2003;22:136.
93. Dijkema SJ, van der Lei B, Kibbelaar RE. New-Fill injections may induce late-onset foreign body granulomatous reaction. Plast Reconstr Surg. 2005;115:1415.
94. Wildemore JK, Jones DK. Persistent granulomatous inflammatory response induced by injectable poly-L-lactic acid for HIV lipoatrophy. Dermatol Surg. 2006;32:1407.
95. Apikian M, Roberts S, Goodman GJ. Adverse reactions to polylactic acid injections in the periorbital area. J Cosmet Dermatol. 2007;6:95.
96. Burgess CM, Quiroga RM. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. Dermatol Surg. 2005;52:233.
97. Wolfram D, Tzankov A, Piza-Katzer H. Surgery for foreign body reactions due to injectable fillers. Dermatology. 2006; 213:300.
98. Waris E, Pakkanen M, Lassila K, et al. Alloplastic injectable biomaterials for soft tissue augmentation: A report of 2 cases with complications associated with a new material (DermaLive) and a review of the literature. Eur J Plast Surg. 2003;26:350.
99. Sidwell RU, Dhillon AP, Butler PEM, Rustin MHA. Localized granulomatous reaction to a semi-permanent hyaluronic acid and acrylic hydrogel cosmetic filler. Clin Exp Dermatol. 2004;29:630.
100. Steenkiste E, Marien K, van den Oord J. Dermalive granuloma: A lesion with distinctive histological features. J Dermatol. 2005;3:1.
101. Vargas-Machuca I, Gonzalez-Guerra E, Angulo J, del Carmen Farina M, Martin L, Requena L. Facial granulomas secondary to Dermalive microimplants: Report of a case with histopathologic differential diagnosis among the granulomas secondary to different injectable permanent filler materials. Am J Dermatopathol. 2006;28:173.
102. Angus JE, Affleck AG, Leach IH, Millard LG. Two cases of delayed granulomatous reactions to the cosmetic filler Dermalive, a hyaluronic acid and acrylic hydrogel. Br J Dermatol. 2006;155:1077.
103. Zide BM. Radiance: Short-term experience. Aesthetic Surg J. 2004;23:495.
104. Jansen DA, Graivier MH. Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation. Plast Reconstr Surg. 2006;118(3 Suppl.):22S.
105. Sklar JA, White SM, Radiance FN. A new soft tissue filler. Dermatol Surg. 2004;30:764.
106. Casavantes LC, Izabel JM. Estabilidad, tolerancia y seguridad de polialquilimida gel (BioAlcamid), endoprotesis inyectable para la correction de defectos mayors en tejidos blandos. Dermatología Cosmética Médica y Quirúrgica. 2004;2:98.
107. Ruden C. Acrylamide and cancer risk: Expert risk assessments and the public debate. Food Chem Toxicol. 2004;42: 335.
108. Pelucchi C, Galeone C, Levi F, et al. Dietary acrylamide and human cancer. Int J Cancer. 2006;118:467.
109. Evstatiev D. Late complications after injections of hydrogel in the breast. Plast Reconstr Surg. 2004;113:1878.
110. Adamyan AA, Svetukhin AM, Skuba N, et al. Polyacrylamide mammary syndrome: Clinical features, diagnosis and treatment. Ann Plast Reconstr Aesthet Surg (Moscow). 2001;4:20.
111. Milanov NO, Donchenko EV, Fisenko EP. Plastic contour correction with polyacrylamide gels. Myth and reality. Ann Plast Reconstr Aesthet Surg (Moscow). 2000;4:63.
112. Niedzielska I, Pajak J, Drugacz J. Late complications after polyacrylamide hydrogel injection into facial soft tissues. Aesthetic Plast Surg. 2006;30:377.
113. Breiting V, Aasted A, Jorgensen A, Opitz P, Rosetzky A. A study on patients treated with polyacrylamide hydrogel injection for facial corrections. Aesthetic Plast Surg. 2004;28:45.
114. Karim RB, Hage JJ, van Rozelaar L, Lange CA, Raaijmakers J. Complications of polyalkylimide 4% injections (BioAlcamid): A report of 18 cases. J Plast Reconstr Aesthet Surg. 2006;59:1409.
115. Cheng NX, Wang YL, Wang JH, Zhang XM, Zhong H. Complications of breast augmentation with injected hydrophilic polyacrylamide gel. Aesthetic Plast Surg. 2002;26:375.
116. Xiaoling F, Yi C, Zhang Y, et al. Analysis of the complications induced by polyacrylamide hydrogel injection. Plast Reconstr Surg. 2004;114:261.
117. Xie PB, Shi AP. Application of polyacrylamide hydrogel in augmentation mammoplasty (in Chinese).Di Yi Da Xue Bao. 2002;22:648.
118. Amin SP, Marmur ES, Goldberg DJ. Complications from injectable polyacrylamide gel, a new nonbiodegradable soft tissue filler. Dermatol Surg. 2004;30:1507.
119. Qiao Q, Wang X, Sun J. Management of postoperative complications of breast augmentation by injected polyacrylamide hydrogel. Aesthetic Plast Surg. 2005;29:156.
120. Bedir S, Kilciler M, Oezgoek Y, Deveci G, Erduran D. Longterm complication due to dextranomer based implant: Granuloma causing urinary obstruction. J Urol. 2004;172:247.
121. Winn A. Factors in selecting medical silicones. Med Plast Biomater. 1996;3:16.
122. Duffy DM. The silicone conundrum: A battle of anecdotes. Dermatol Surg. 2002;28:590.
123. Rongioletti F, Cattarina G, Sottofattori E, Rebora A. Granulomatous reaction after intradermal injections of hyaluronic acid gel. Arch Dermatol. 2003;139:815.
124. Wolters M, Lampe H. Nicht-operative Faltenbehandlung im Gesicht. Plast Chir. 2003;2:69.
125. Christensen L, Breiting VB, Janssen M, Vuust J, Hogdall E. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg. 2005;29:34.
126. Fischer J, Metzler G, Schaller M. Cosmetic permanent fillers for soft tissue augmentation: A new contraindication for Interferon therapies. Arch Dermatol. 2007;143:507.
127. Bardazzi F, Ruffato A, Antonucci A, Balestri R, Tabanelli M. Cutaneous granulomatous reactiontoinjectable hyaluronic acid gel: Another case. J Dermatolog Treat. 2007;18:59.
128. Al-Qattan MM. Late Artecoll granulomas aggravated by pregnancy. Ann Plast Surg. 2007;58:592.
129. Barcaro Machado BH. Complicacoes de implantes e preenchimentos em face e corpo. Presented at Forum Implantes, Inclusoes e Preenchimentos, Sao Paulo, Brazil, July 1-2, 2005.
130. Coleman SR. Structural fat grafting: More than a permanent filler. Plast Reconstr Surg. 2006;118(3 Suppl.): 108S.